Abstract
The cardioplegia solution, HTK (histidine-tryptophan-ketoglutarate) (Bretschneider et al. 1975, 1984; Bretschneider 1980), was primarily developed to improve myocardial protection, as compared with periods of ischemia, during artificial cardiac arrest in open heart surgery. It has since become a routine clinical procedure (Preusse et al. 1987). According to our results, this solution also significantly improves ischemic tolerance of kidneys (Kallerhoff et al. 1985a, b, 1986, 1987c). The superiority over simple ischemia or over the Euro Collins solution holds for “cold” as well as for “warm” ischemia (Kallerhoff et al. 1988a). Renal ischemic tolerance was increased from 15–20 min to 2 h at normothermia (Kallerhoff et al. 1986). There have now been several clinical applications of this method (Blech et al. 1988; Kallerhoff et al. 1988b).
Supported by the DFG, SFB 330-Organprotektion Dedicated, gratefully, to Prof. Dr. W. Knipper
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andrews PM, Bates SP (1986) Dietary protein prior to renal ischemia dramatically affects postishemic kidney function. Kidney Int 30: 299–303
Blech M, Kallerhoff M, Kehrer G, von Romatowsky HJ, Mündemann-Schultz Ch, Helmchen U, Truss F, Bretschneider HJ (1988) Klinische Anwendung der kardioplegischen Lösung HTK nach Bretschneider zur in-situ Protektion der Niere. Urologe [Ausg A] 27: 44–48
Bretschneider HJ (1980) Myocardial protection. Thorac Cardiovasc Surg 28: 295–302
Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG (1975) Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg 16: 241–260
Bretschneider HJ, Gebhard MM, Preusse CJ (1984) Cardioplegia - principles and problems. In: Sperelakis N (ed) Physiology and pathophysiology of the heart. Martinus Nijhoff, Boston, pp 605–616
Brezis M, Rosen S, Silva P, Epstein FH (1984) Renal ischemia: a new perspective. Kidney Int 26: 375–383
Cassola AC, Mollenhauer M, Frömter E (1983) The intracellular chloride activity of rat kidney proximal tubular cells. Pflügers Arch 399: 259–265
Deetjen P, Kramer K (1961) Die Abhängigkeit des O2Verbrauches der Niere von der Na+-Rück- resorption. Pflügers Arch 273: 636–650
Fitzpatrick JM, Monson JRT, Gunther PA, Watkinson LE, Wickham JEA (1982) Renal accumulation of ammonia: the cause of post-ischemic functional loss and the “blue line”. Br J Urol 54: 608–612
Greger R (1985) Ion transport mechanisms in thick ascending limb of Henle’s loop of mammalian nephron. Physiol Rev 65: 760–797
Guder WG, Wagner S, Wirthenson G (1986) Metabolic fuels along the nephron: pathways and intracellular mechanisms of interaction. Kidney Int 29: 41–45
Hochachka PW, Mommsen TP (1983) Protons and anaerobiosis. Science 219: 1391–1397
Jones DP (1986) Renal metabolism during normoxia, hypoxia, and ischemic injury. Ann Rev Physiol 48: 33–50
Kallerhoff M, Kehrer G, Siekmann W, Blech M, Gebhard MM, Helmchen U, Bretschneider HJ ( 1985 a) Experimentelle Anwendung der Kardioplegischen Lösung HTK nach Bretschneider für eine in-situ Protektion von Nieren. In: Harzmann R (eds) Experimentelle Urologie. Springer, Berlin Heidelberg New York, pp 180–188
Kallerhoff M, Hölscher M, Kehrer G, Kläß G, Bretschneider HJ (1985b) Effects of preservation conditions and temperature on tissue acidification in canine kidneys. Transplantation 39: 485–489
Kallerhoff M, Blech M, Kehrer G, Kleinert H, Siekmann W, Helmchen U, Bretschneider HJ (1986) Post-ischemic renal function after kidney protection with the HTK-solution of Bretschneider. Urol Res 14: 271–277
Kallerhoff M, Blech M, Kehrer G, Kleinert H, Langheinrich M, Siekmann W, Helmchen U, Bretschneider HJ (1987a) Short-term perfusion and “equilibration” of canine kidneys with protective solutions. Urol Res 15: 5–12
Kallerhoff M, Blech M, Kehrer G, Kleinert H, Langheinrich M, Siekmann W, Helmchen U, Bretschneider HJ (1987b) Effects of glucose in protected ischemic kidneys. Urol Res 15: 215–222
Kallerhoff M, Blech M, Kehrer G, Kleinert H, Langheinrich M, Siekmann W, Helmchen U, Bretschneider HJ (1987c) Nierenfunktionsparameter nach Ischämiebelastung unter der Euro-Collins- Lösung oder unter der kardioplegischen Lösung HTK nach Bretschneider. Urologe [Ausg A] 26: 96–103
Kallerhoff M, Blech M, Isemer FE, Kehrer G, Kleinert H, Helmchen U, Bretschneider HJ (1988a) Metabolie, energetic, and structural changes in protected and unprotected kidneys at tempera-tures of 1°C and 25°C. Urol Res 16: 57–62
Kallerhoff M, Blech M, Kehrer G (1988b) Nierenprotektion in situ mit der HTK-Lösung nach Bretschneider. Verh Dt Ges Urologie 40 (in press)
Katz AI (1986) Distribution and function of classes of ATPases along the nephron. Kidney Int 29: 21–31
Kehrer G, Kallerhoff M, Probst R, Siekmann W, Blech M, Bretschneider HJ, Helmchen U (1985) Construction and experimental application of a catheter for selective arterial kidney perfusion in situ. Urol Res 13: 85–89
Koyuncuôglu H, Wildmann J, Berkmann K, Matthaei H (1982) The effects of D-and/or L-aspartic acids on the total weight of body, the weights of certain organs, and their protein, triglyceride and glycogen contents. Arzneimittel-Forsch/Drug Res 32 (II): 738–741
Mandel LJ (1986) Primary active sodium transport, oxygen consumption and ATP: coupling and regulation. Kidney Int 29: 3–9
Mason J, Beck F, Dörge A, Rick R, Thurau K (1981) Intracellular electrolyte composition following renal ischemia. Kidney Int 20: 61–70
Preusse CJ, Schulte HD, Bircks W (1987) High volume cardioplegia. Ann Chir Gyn 76: 39–45
Riggs AF (1988) The Bohr effect. Ann Rev Physiol 50: 181–204
Schlier RW, Arnold PE, van Putten VJ (1987) Cellular calcium in ischemic acute renal failure: role of calcium entry blockers. Kidney Int 32: 313–321
Siegel NJ, Glazier WB, Chaudry IH, Gaudio KM, Lytton B, Baue AE, Kashgarian M (1980) Enhanced recovery from acute failure by the postischemic infusion of adenine nucleotides and magnesium chloride in rats. Kidney Int 17: 338–349
Silbernagel S, Foulkes EC, Deetjen P (1975) Renal transport of amino acids. Rev Physiol Biochem Pharmacol 74: 105–167
Soltoff STP (1986) ATP and the regulation of renal cell function. Ann Rev Physiol 48: 9–31
Verkh L, Freier DT, Celik C (1986) Changes in concentration of amino acids and other metabolites during hypothermic perfusion of the canine kidney. Cryobiology 23: 366–370
Vinay P, Lemieux G, Gougoux A, Halperin M (1986) Regulation of glutamine metabolism in dog kidney in vivo. Kidney Int 29: 68–79
Wingo CS (1986) Effect of acidosis on chloride transport in the cortical thick ascending limb of Henle perfused in vitro. J Clin Invest 78: 1324–1330
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kallerhoff, M. et al. (1989). Improvement of In Situ Renal Protection Against Complete Ischemia Through the Replacement of Chloride by Aspartate in the HTK Solution of Bretschneider. In: Rübben, H., Jocham, D., Jacobi, G.H. (eds) Investigative Urology 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74438-9_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-74438-9_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74440-2
Online ISBN: 978-3-642-74438-9
eBook Packages: Springer Book Archive